期刊文献+

腹膜透析对尿毒症患者血同型半胱氨酸的清除作用

Effects of peritoneal dialysis on clearance of homocysteine in patients with uremia
原文传递
导出
摘要 目的探讨腹膜透析对尿毒症患者血清同型半胱氨酸(Hcy)的清除作用及影响因素。方法采用酶转换法检测20例腹膜透析患者血清、24-h尿和24-h腹透液中Hcy、β2微球蛋白、尿素氮和肌酐水平,计算残余肾和腹膜透析Hcy清除率、尿素清除指数和肌酐清除率。结果 20例腹膜透析患者血清和腹膜透析液Hcy浓度分别为(13.03±13.14)μmol/L和(5.57±3.02)μmol/L,两者呈正相关(r=0.608,P<0.01)。24-h腹膜透析对Hcy的清除量亦与血清Hcy浓度呈正相关(r=0.704,P<0.01)。结论腹膜透析对Hcy有一定的清除作用。 Objective To investigate the effect of peritoneal dialysis on the clearance of homocysteine(Hey) and its influence factors in the patients with uremia. Methods Hcy contents in serum,24-hour urine and 24-hour peritoneal dialysate were detected in 20 patients with uremia. The indexes of β2-microglobulin(β2-MG), C-reactive protein(CRP), creatinine and urea were examined as well. Results Hcy levels in serum and peritoneal dialysate were (13. 03± 13.14)μmol/L and (5.57± 3.02)μmol/L, respectively. Hcy level in serum dialysate(r=0. 608, P〈0. 01). The amount of was positively correlated with that in peritoneal Hcy cleared by 24-hour peritoneal dialysis was positively correlated with serum level of Hcy(r=0. 704,P〈0. 01). Conclusions Hcy could be partly cleared by peritoneal dialysis.
出处 《江苏医药》 CAS 北大核心 2014年第15期1750-1752,共3页 Jiangsu Medical Journal
基金 国家十二五科技支撑计划项目(2011BAI10B00)
关键词 尿毒症 腹膜透析 同型半胱氨酸 Uremia Peritoneal dialysis Homocysteine
  • 相关文献

参考文献6

  • 1Sen U, Rodriguez WE, Tyagi N, et al. Ciglitazone, a PPAR7 agonist, ameliorates diabetic nephropathy in part through homocysteine clearance[-J]. Am J Physiol Endoerinol Metab, 2008,295 (5) : E1205-E1212.
  • 2McCully KS. Homocysteine and vascular disease[J-]. Nat Med, 1996,2(4) : 386-389.
  • 3Zoccali C,Jager KJ. Hyperhomocysteinemia: a renal and cardi- ovascular risk factor[J]? Nat Rev Nephrol, 2010,6 (12) : 695- 696.
  • 4Anwar WiGufant JL,Abdelmouttaleh I,et al. Hyperhomocys- teinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented en&stage renal disease patients undergoing hemodialysis[J]. Clin Chem Lab Med,2001,39(8) : 747-752.
  • 5Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocys- teinemia in endothelial dysfunction and atherothrombotic disease[J]. Cell Death Differ, 2004,11 (Suppl 1) :S56 -S64.
  • 6Widiana IG,Suwitra K. Relationship between creatinine clear- ance and plasma homocysteine levels in predialytic chronic renal failure patients[J]. Acta Med Indones,2004,36(1): 15-18.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部